Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1141-1146

  Yoshida, Hiromi ^a   Kijima, Hiroshi ^a,b   Terasaki, Yasuko ^c   Suto, Akihiko ^a   Takeshita, Toshio ^a   Omiya, Harumi ^a   Shimojima, Kaori ^a   Shimbori, Masumi ^a   Sato, Tadamitsu ^a   Sato, Sakiyo ^a   Onoda, Noboru ^a   Yamazaki, Hitoshi ^a,b   Tamaoki, Norikazu ^b   Ueyama, Yoshito ^b   Nakamura, Masato ^b  

^a Yamato Municipal Hospital   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c KYORIN UNIVERSITY   (Japan)

Author keywords

Breast cancer; Immunohistochemistry; Lymph node status; Metastasis; Nm23

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL;

EID: 13144251134     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1141     Document Type: Article

References (26)

1. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson VP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
2. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL Jr, Shows TB, Mathew S, Murty VV and Chaganti RS: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes nm23-1 and nm23-2. Oncogene 8: 497-502, 1993.
3. Chen H-C, Wang L and Banerjee S: Isolation and characterization of the promoter region nm23-H1, a metastasis suppressor gene. Oncogene 9: 2905-2912, 1994.
4. Stahl JA, Leone A and Rosengard AM: Identification of a second human nm23 gene, nm23-H2. Cancer Res 48: 6550-6554, 1991.
5. Rosengard AM, Krutzsch HC and Sheam A: Reduced nm23/Awd protein in tumor metastasis and aberrant Drosophila development. Nature 342: 177-180, 1989.
6. Urano T, Furukawa K and Shiku H: Expression of nm23/NDP kinase proteins on the cell surface. Oncogene 8: 1371-1376, 1998.
7. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA and Steeg PS: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65: 25-35, 1991.
8. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
9. Hennessy C, Henry LA, May FEB, Westley BR, Augus B and Lennard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991.
10. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki Y, Kurashima C, Utsuyama M and Hirokawa K: Positive relationship between expression of antimetastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83: 1249-1250, 1991.
11. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T and Shiku H: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55: 66-71, 1993.
12. Royds JA, Stephenson J, Rees RC, Shorthouse AJ and Silcocks PB: Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 85: 727-731, 1993.
13. Duenas-Gonzalez A, Abad-Hernandez MM, Garcia-Mata J, Paz-Bouza JI, Cruz-Hernandez JJ and Gonzalez-Sarmiento R: Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings. Cancer Lett 101: 137-142, 1996.
14. Barrens R, Massed S, Barker E, Rosengard AM, Noggin DL, Crewel T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA and Steeg PS: Low nm23 protein expression in infiltrating ductal breast carcinoma correlates with reduced patient survival. Am J Pathol 139: 245-250, 1991.
15. Goodall RJ, Dawkins HJS, Robbins PD, Haehnel E, Sarna M, Haehnel R, Papadimitriou JM, Harvey JM and Sterrett GF: Evaluation of the expression of nm23-H1 mRNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue. Pathology 26: 423-428, 1994.
16. Sastre-Garau X, Lacombe ML, Jouve M, Veron M and Magdelenat H: Nucleoside diphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph node metastasis. Int J Cancer 50: 533-538, 1992.
17. Sawan A, Lascu I, Veron M, Anderson JJ, Wright C, Horne CHW and Agnus B: NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J Pathol 172: 27-34, 1994.
18. Rosen PP and Oberman HA: Tumors of the mammary gland. In: Atlas of Tumor Pathology. 3rd series, fascicle-7. Armed Forces Institute of Pathology, Washington, pp7-10, 1993.
19. Wagner PD, Steeg PS and Vu ND: Tow-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA 94: 9000-9005, 1997.
20. Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K and Steeg PS: Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nat Med 3: 395-401, 1997.
21. Russell RL, Geisinger KR, Mehta RR, White WL, Shelton B and Kute TE: nm23 - relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Cancer 79: 1158-1165, 1997.
22. MacDonald NJ, Freije JMP, Stracke ML, Manrow RE and Steeg PS: Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem 271: 25107-25116, 1996.
23. MacDonald NJ, De la Rose A and Steeg PS: The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 31A: 1096-1100, 1995.
24. Hewlett AR, Petersen OW, Steeg PS and Bissell MJ: A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844, 1994.
25. Hahnel E, Dawkins H, Robbins P and Hahnel R: Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues. Int J Cancer 58: 157-160, 1994.
26. Simpson JF, O'Malley F, Dupont WD and Page DL: Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Cancer 73: 2352-2358, 1994.